Fifty four patients with peripheral nerve syndromes were seen during a 15 month period in a population of about 1500 HIV infected patients at all stages of the disease. Distal symmetrical peripheral neuropathies were seen in 38 of the 54 patients, (11.5% of AIDS patients) and could be distinguished into two forms. The most common (n = 25) was a painful peripheral neuropathy during AIDS, which is distinct clinically and pathologically, having axonal atrophy, and is associated with cytomegalovirus infection at other sites. The 13 non-painful neuropathies seen were more heterogenous. Lumbosacral polyradiculopathy associated with cytomegalovirus and lymphomatous mononeuritis multiplex occurred in fewer than 1% of AIDS patients. Mononeuropathies were seen in 3% of AIDS patients. No patients with acute or chronic inflammatory demyelinating polyradiculoneuropathies were seen. The annual incidence of neuropathies during the AIDS related complex stage was less than 1%; none were seen in asymptomatic HIV seropositive patients.
A variety of peripheral nerve syndromes have been described at different stages of HIV infection, from seroconversion to AIDS. Most described are case reports or small selected series which do not estimate the incidence. A large prospective study of HIV positive patients found that peripheral neuropathies were rare', and a cross sectional study of 40 hospitalised patients with AIDS found that 33% had peripheral neuropathies.2 We report the nature and frequency of peripheral nerve syndromes seen during a 15 month prospective, population based, referral series from a population of about 1500 HIV positive patients3 and discuss the findings in relation to current classifications of peripheral nerve syndromes.
Methods

PATIENTS
Patients were included if they had been referred to the neurology department with peripheral nerve syndromes between 1 September 1988 and 31 December 1989 from the population of HIV infected patients who attended hospitals and clinics in the East Riverside area. Patients were excluded if they had been exposed to neurotoxins (drugs such as vincrinstine, isoniazid, or thalidomide or regularly took more than 40 units of alcohol a week) or had other systemic conditions, not related to HIV, associated with peripheral neuropathy (such as diabetes or uraemia) or had a family history of peripheral neuropathy. Patients were classified as having AIDS according to the CDC criteria4; they were classified as having AIDS related complex if they were HIV positive and had persistent generalised lymphadenopathy, fever, oral hairy leukoplakia, oral candidiasis, herpes zoster radiculitis, and foliculitis but lacked AIDS defining opportunistic infections or tumours. At the time of the study the neurotoxic nucleoside analogues DDI and DDC were not being used.
At the start of the study (September 1988) 1353 HIV positive patients were being followed up at these clinics. A total of 748 had AIDS related complex and 261 had AIDS (C Dalton, personal communication). By September 1989 there were 1765 HIV positive patients, of whom 778 had AIDS related complex and 297 had AIDS. Of the HIV positive patients, 83% were homosexual or bisexual, 4-4% were drug misusers, and 2 5% were heterosexual and did not misuse drugs. For 10% the risk factors were unknown. There were no haemophilics. Between September 1988 and 1 September 1989, 105 patients died with AIDS in this population.
Patients were assessed with a standardised neurological examination. The five found to have bilateral upper motor neuron signs at presentation of peripheral neuropathy will be considered separately to allow the clinical features of the neuropathy to be studied in isolation. The following HIV related and nutritional data were collected in a standardised way: duration of AIDS, previous HIV related infections (using CDC criteria4), CD4 count (ACSCAN TM, Becton Dickinson), body mass index (weight divided bv height squared), serum B-12 concentration (DICO-PAC radioimmunoassays; normal range 210-900 pg/ml), and serum albumin concentration. The same data were collected for the Natzure anid itncidenice ofperipheral nerve syndronies in HIV infection tiplex, polyradiculopathy, or mononeuropathy). The distal symmetrical peripheral neuropathies were distinguished as those with pain and those without. Pain was defined as an unpleasant sensory experience subjectively recognised by the patient and mentioned in the history. No formal pain scale was used. This distinction is further considered in the discussion.
Standardised electrophysiological studies and pathological studies of the sural nerve were performed using previously described methods.
CONTROL GROUPS
Neurologically asymptomatic AIDS patientsPatients with AIDS but without signs or symptoms of peripheral neuropathy were assessed clinically (n = 30) and were studied electrophysiologically (n = 30) and pathologically (n = 5). Data related to HIV and nutrition were noted as described above. The group has previously been described in detail;7 and it provided electrophysiological and pathological control data (see table 4 ).
Patients with AIDS admitted to hospital sequentially (n = 30) were assessed separately and the standardised HIV related data were collected. This data has been published previously. 8 chair bound because of extreme contact pain. The pain was limited to the legs in all but two patients, mostly affecting the feet (n = 17). It was limited to the toes in two patients and to the soles in one. One patient had low back pain at the onset. The symptoms were symmetrical in all but four patients. The onset of pain was subacute, usually beginning with stiffness in the toes, later progressing to become painful. Maximum pain usually occurred within two to four weeks (13/20) ; in one patient the pain reached its peak in less than a week; in another it took over two months. The pain usually improved spontaneously (in eight patients it resolved completely) but in six patients it persisted unchanged. One patient had recurrence of pain followed by further improvement. Some symptomatic relief was obtained with carbamazepine in seven patients and amitriptyline in eight, but both drugs failed to help in one instance. Two patients reported that marijuana alleviated the pain. Two patients had Kaposi's sarcoma in the feet but it was thought unlikely to be the cause of the pain as neither the site nor the time course of the pain matched that of the Kaposi's sarcoma.
All patients complained of numbness, which was again mostly in the feet (17/20) , to mid-calf in one patient, only in the toes in one, and in the soles in another. Three patients noted numbness in their fingertips.
Paraesthesia was felt in the feet in 13, to midcalf in one, in the toes in one, and the fingertips in two. No patients complained spontaneously of weakness. Three patients had observed their toes moving spontaneously, an observation confirmed in two. In two patients, mononeuropathies had been the first indication of peripheral nerve dysfunction (meralgia paraesthetica in one and a probable common peroneal palsy in the other). A further patient had an episode of meralgia paraesthetica six months before the onset of his pain. Half the patients had noted that they became impotent at the onset of pain; in only two was this volunteered spontaneously. A further three noted urinary symptoms; one had difficulty with micturition and two had frequency.
Distal weakness with wasting of extensor digitorum brevis was found in five of 20 patients. In a further patient, distal weakness developed 10 months after the onset of pain. At the first assessment the ankle reflexes were normal in 10, impaired in five, and absent in five. There was a progressive loss of ankle reflexes, with the reflex being absent at the final assessment in 14 patients and impaired in three. No patient had distal lower limb oedema.
Sensory abnormalities were predominantly of superficial sensation. All patients had alteration of light touch or pinprick (loss of light touch in 12 and pinprick in 15). Subjective changes extended to the ankle while the loss was usually in the toes. In all but three patients the changes were limited to the legs. In these three the loss in the arms was restricted to the fingertips in two and to the little finger in one. Temperature sensation was altered in 15; vibration sense was abnormal in 15 but only to the level of the toes. Position sense was impaired at the toes in six. In eight, the sensory signs did not alter. In 10 there were changes: improvement in two, a deterioration in eight. The change was slight with the exception of those patients who were initially assessed within one or two weeks of the onset of their symptoms.
The clinical features of patients with peripheral neuropathies are summarised in table 3 . The clinical features of the five patients who also had signs of a myelopathy at presentation were similar, but in addition they had bilateral pyramidal weakness and pathologically brisk reflexes in the arms and at the knee. The ankle reflexes were abnormal in all five at presentation. Twenty three patients were followed up until death (median 7 months, range 1-21 months); two were alive at review at 10 and the foot in five, and the knees in two. Sensc loss in the fingers was found in five patien posterior column loss was found in sevw
The symptoms and signs of the neuropat were progressive in four patients, static four, and apparently improved in one. T' patients had pes cavus. Four patients w myelopathy and neuropathy had similar cli cal pictures. Twelve patients were followed until dee (median 8 months, range 1-17 months); o was reviewed nine months after onset symptoms. Table 4 summarises the electrophysiolc findings. Sensory nerve action potentials w reduced, more in the legs than in the arn Sensory conduction velocities were sign cantly reduced when compared with those neurologically asymptomatic AIDS patier Motor action potentials in the ulnar nerve ( not differ from those in this control groi The common peroneal compound mus action potential was significantly small Distal motor latencies of the common p oneal were slightly prolonged. There was difference in the ulnar nerve distal mo latency. The F waves in extensor digitori brevis were not recordable in 46% of 1 Fuller, Jracobs, Guiloff patient, aged 34, presented with multiple cranial nerve palsies and a cervical radiculopathy and was found to have lymphomatous meningitis.
Electrophysiology
ISOLATED MONONEUROPATHIES
Three patients with isolated mononeuropathies had AIDS related complex and eight had AIDS. Their mean (SD) age was 41-1 (6-7) years. The patients with AIDS related complex had a median CD4 count of 160/,ul and a mean body mass index of 26&6. Those with AIDS had a median CD4 count of 55/,il and a body mass index of 21-6. The nerve most commonly affected was the lateral cutaneous nerve of the thigh (n = 5), followed by the common peroneal (n = 3) and median (n = 3) nerves. The neuropathies presented usually either during or after the patients had been admitted to hospital (7/11) for a variety of infections or tumours. In most no local cause was found. In one patient a meralgia paraesthetica occurred at the same time and side as inguinal lymphadenopathy due to lymphoma; it resolved with treatment of the lymphoma. In a further seven patients the mononeuropathy resolved spontaneously. In three (one with meralgia paraesthetica, one common peroneal and one median), the symptoms persisted.
Results of electrophysiological studies in nerves other than those affected clinically did not differ from those in neurologically asymptomatic AIDS patients.
POLYRADICULOPATHY
Two patients with lumbosacral polyradiculopathy have been reported in detail elsewhere.9
Discussion
We have described the range of peripheral nerve syndromes seen in a 15 month period in a relatively stable outpatient population of HIV positive patients at various stages of their disease. As the population was known at two points, an estimate of the population halfway through the study can be obtained and this can be used to estimate the 15 month incidence of the various syndromes (table 5) . Painful peripheral neuropathy was the most common, occurring in 7 5% of AIDS patients; non-painful peripheral neuropathies were seen in 4%. Mononeuropathy occurred in 3% of AIDS patients, and mononeuritis multiplex and a lumbosacral polyradiculopathy were each seen in 06%. Neuropathies during the AIDS related complex stage occurred in fewer than 1% of patients.
These estimates contain several possible sources of inaccuracy. Firstly, the patients may not have been referred to the neurology service. Secondly, the population was changing and patients may have sought treatment elsewhere. Thirdly, patients were excluded when they had other potential causes for neuropathy, even though these causes may not have produced the relevant neuropathy. These exclusions prevent this study from assessing whether pre-existing neuropathy predisposes to the development of PPN.
In table 5 the incidence and relative rates of different patterns of neuropathies are compared with those of other unselected series, including case series, prevalence studies, and a point prevalence study. In all studies, distal symmetrical peripheral neuropathies were the most common and account for some 90% of all neuropathies in AIDS. In early series they were estimated to affect 2-5% of AIDS patients.'01' In a study comparable to ours from Baltimore,'2 13% of AIDS patients had distal symmetrical peripheral neuropathies. In our series, lumbosacral polyradiculopathy and mononeuritis multiplex each were found in fewer than 1% of patients with AIDS and AIDS related complex.
Other researchers have described a syndrome similar to painful peripheral neuropathy, usually grouped together with non-painful neuropathies, as "predominantly sensory neuropathy," "sensory motor neuropathy," "distal symmetrical polyneuropathy," or "painful neuropathy".'2-'5 When the clinical features were similar to those pathology. This is supported by the F wave velocities not differing from those in our neurologically asymptomatic AIDS controls. Axonal loss was found in all our cases of distal symmetrical peripheral neuropathy and has been consistently reported by others.'3 ' 1 [20] [21] Myelinated fibre densities were reduced to a similar degree in this and other studies.' 23 The myelinated fibre density in patients with PPN was 20% lower than that in neurologically asymptomatic controls but no different from that in patients with OPN. The density of unmyelinated axons was the same as in the asymptomatic controls (22 260 v 22 016). The unmyelinated fibre density and the unmyelinated axon density of the patients with non-painful peripheral neuropathies were similar to those of patients with painful neuropathies.
The only morphological finding that distinguished patients with a painful peripheral neuropathy from those with other peripheral neuropathies and the neurologically asymptomatic AIDS controls was axonal atrophy. Qualitatively, this was found in all eight sural nerves of patients with painful neuropathies but not in eight nerves of patients with nonpainful neuropathies. Quantitatively, it was seen in all four patients with painful neuropathies studied but in none of the three patients with non-painful distal symmetrical neuropathies nor in any neurologically asymptomatic AIDS patients., A two tailed Fisher's exact test on these data rejects the null hypothesis of independence between PPN and axonal atrophy (p < 0.03).6 There was no concomitant atrophy of unmyelinated axons. 6 These findings can be interpreted in several ways. Firstly, it can be speculated that the subclinical peripheral neuropathy found in neurologically asymptomatic AIDS,7 the other non-painful neuropathies, and the painful peripheral neuropathy in AIDS represent different points in a continuous spectrum. The significantly longer duration of OPN than PPN at presentation (table 3) is against the idea that a non-painful neuropathy progresses to a point when it becomes painful. Alternatively, the painful and the non-painful peripheral neuropathies may represent distinct entities which occur in the setting of a non-specific "axonal. loss of chronic disorders." Evidence of this loss in our study on AIDS related subclinical peripheral neuropathy,7 the relatively stereotyped clinical presentation of PPN, and the findings of associated axonal atrophy and CMV infection in PPN would all point to PPN as a distinct entity rather than as part of a continuum and raise the question as to whether it should represent a subdivision in DSPN.24
The non-painful distal symmetrical peripheral neuropathies reported here seemed to be more heterogeneous than PPN and two patients had pes cavus, suggesting an inherited neuropathy despite the lack of a family history. In addition, this group had a significantly lower body mass index, suggesting a possible role for nutritional factors. 
